UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF
REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES
EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER
SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number: 001-36867
Allergan plc
(Exact name of registrant as specified in its
charter)
Clonshaugh Business and Technology Park
Coolock, Dublin, D17 E400, Ireland
+353 1 435 7700
(Address, including zip code, and telephone
number, including area code, of registrant’s principal executive
offices)
Ordinary Shares, par value of $0.0001 per
share
Guarantees of Allergan, Inc.’s 3.375% notes due
2020
Guarantees of Allergan Sales, LLC’s 4.875% notes
due 2021
Guarantees of Allergan Sales, LLC’s 5.000% notes
due 2021
Guarantees of Allergan Finance, LLC’s 3.250%
notes due 2022
Guarantees of Allergan, Inc.’s 2.800% notes due
2023
Guarantees of Allergan Finance, LLC’s 4.625%
notes due 2042
(Title of each class of securities covered by
this Form)
None
(Titles of all other classes of securities for
which a duty to file reports under section 13(a) or 15(d)
remains)
Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file
reports:
|
|
|
|
|
|
|
|
|
Rule 12g-4(a)(1)
|
|
☒
|
|
|
|
|
Rule 12g-4(a)(2)
|
|
☐
|
|
|
|
|
Rule 12h-3(b)(1)(i)
|
|
☒
|
|
|
|
|
Rule 12h-3(b)(1)(ii)
|
|
☐
|
|
|
|
|
Rule 15d-6
|
|
☐
|
|
|
|
|
Rule 15d-22(b)
|
|
☐
|
|
|
Approximate number of holders of record as of the certification or
notice date:
Ordinary Shares, par value of $0.0001 per share: One
(1) holder
Guarantees of Allergan, Inc.’s 3.375% notes due
2020: Zero (0) holders
Guarantees of Allergan Sales, LLC’s 4.875% notes due
2021: Zero (0) holders
Guarantees of Allergan Sales, LLC’s 5.000% notes due
2021: Zero (0) holders
Guarantees of Allergan Finance, LLC’s 3.250% notes
due 2022: Zero (0) holders
Guarantees of Allergan, Inc.’s 2.800% notes due
2023: Zero (0) holders
Guarantees of Allergan Finance, LLC’s 4.625% notes
due 2042: Zero (0) holders
